Recent advances in understanding breast cancer and emerging therapies with a focus on luminal and triple-negative breast cancer

por El Hachem, Georges, Gombos, Andrea, Awada, Ahmad
Publicado 2019

Clinical development of insulin-like growth factor receptor—1 (IGF-1R) inhibitors: At the crossroad?

por Gombos, Andrea, Metzger-Filho, Otto, Dal Lago, Lissandra, Awada-Hussein, Ahmad
Publicado 2012

Targeting immune checkpoints in breast cancer: an update of early results

por Solinas, Cinzia, Gombos, Andrea, Latifyan, Sofiya, Piccart-Gebhart, Martine, Kok, Marleen, Buisseret, Laurence
Publicado 2017

Case Report: Mammary and rectal metastases from an ovarian cancer: report of two cases and review of literature

por Amzerin, Mounia, Garcia, Camilo, Stanciu, Claudia, Veys, Isabelle, Awada, Ahmad, Errihani, Hassan, Gombos, Andrea
Publicado 2014

Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications

por Jézéquel, Pascal, Kerdraon, Olivier, Hondermarck, Hubert, Guérin-Charbonnel, Catherine, Lasla, Hamza, Gouraud, Wilfried, Canon, Jean-Luc, Gombos, Andrea, Dalenc, Florence, Delaloge, Suzette, Lemonnier, Jérôme, Loussouarn, Delphine, Verrièle, Véronique, Campone, Mario
Publicado 2019

FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancer

por Gombos, Andrea, Venet, David, Ameye, Lieveke, Vuylsteke, Peter, Neven, Patrick, Richard, Vincent, Duhoux, Francois P., Laes, Jean-Francois, Rothe, Françoise, Sotiriou, Christos, Paesmans, Marianne, Awada, Ahmad, Guiot, Thomas, Flamen, Patrick, Piccart-Gebhart, Martine, Ignatiadis, Michail, Gebhart, Géraldine
Publicado 2021

Author Correction: FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancer

por Gombos, Andrea, Venet, David, Ameye, Lieveke, Vuylsteke, Peter, Neven, Patrick, Richard, Vincent, Duhoux, Francois P., Laes, Jean-Francois, Rothe, Françoise, Sotiriou, Christos, Paesmans, Marianne, Awada, Ahmad, Guiot, Thomas, Flamen, Patrick, Piccart-Gebhart, Martine, Ignatiadis, Michail, Gebhart, Géraldine
Publicado 2022

Feasibility Study of EndoTAG-1, a Tumor Endothelial Targeting Agent, in Combination with Paclitaxel followed by FEC as Induction Therapy in HER2-Negative Breast Cancer

por Ignatiadis, Michail, Zardavas, Dimitrios, Lemort, Marc, Wilke, Celine, Vanderbeeken, Marie-Catherine, D’Hondt, Veronique, De Azambuja, Evandro, Gombos, Andrea, Lebrun, Fabienne, Dal Lago, Lissandra, Bustin, Fanny, Maetens, Marion, Ameye, Lieveke, Veys, Isabelle, Michiels, Stefan, Paesmans, Marianne, Larsimont, Denis, Sotiriou, Christos, Nogaret, Jean-Marie, Piccart, Martine, Awada, Ahmad
Publicado 2016

What if the future of HER2‐positive breast cancer patients was written in miRNAs? An exploratory analysis from NeoALTTO study

por Pizzamiglio, Sara, Cosentino, Giulia, Ciniselli, Chiara M., De Cecco, Loris, Cataldo, Alessandra, Plantamura, Ilaria, Triulzi, Tiziana, El‐abed, Sarra, Wang, Yingbo, Bajji, Mohammed, Nuciforo, Paolo, Huober, Jens, Ellard, Susan L., Rimm, David L., Gombos, Andrea, Daidone, Maria Grazia, Verderio, Paolo, Tagliabue, Elda, Di Cosimo, Serena, Iorio, Marilena V.
Publicado 2021

Who are the women who enrolled in the POSITIVE trial: A global study to support young hormone receptor positive breast cancer survivors desiring pregnancy()

por Partridge, Ann H., Niman, Samuel M., Ruggeri, Monica, Peccatori, Fedro A., Azim, Hatem A., Colleoni, Marco, Saura, Cristina, Shimizu, Chikako, Sætersdal, Anna Barbro, Kroep, Judith R., Mailliez, Audrey, Warner, Ellen, Borges, Virginia F., Amant, Frédéric, Gombos, Andrea, Kataoka, Akemi, Rousset-Jablonski, Christine, Borstnar, Simona, Takei, Junko, Lee, Jeong Eon, Walshe, Janice M., Borrego, Manuel Ruíz, Moore, Halle CF., Saunders, Christobel, Cardoso, Fatima, Susnjar, Snezana, Bjelic-Radisic, Vesna, Smith, Karen L., Piccart, Martine, Korde, Larissa A., Goldhirsch, Aron, Gelber, Richard D., Pagani, Olivia
Publicado 2021

Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening Initiative

por Aftimos, Philippe, Oliveira, Mafalda, Irrthum, Alexandre, Fumagalli, Debora, Sotiriou, Christos, Gal-Yam, Einav Nili, Robson, Mark E., Ndozeng, Justin, Di Leo, Angelo, Ciruelos, Eva M., de Azambuja, Evandro, Viale, Giuseppe, Scheepers, Elsemieke D., Curigliano, Giuseppe, Bliss, Judith M., Reis-Filho, Jorge S., Colleoni, Marco, Balic, Marija, Cardoso, Fatima, Albanell, Joan, Duhem, Caroline, Marreaud, Sandrine, Romagnoli, Dario, Rojas, Beatriz, Gombos, Andrea, Wildiers, Hans, Guerrero-Zotano, Angel, Hall, Peter, Bonetti, Andrea, Larsson, Karolina Fs, Degiorgis, Martina, Khodaverdi, Silvia, Greil, Richard, Sverrisdóttir, Ásgerdur, Paoli, Marta, Seyll, Ethel, Loibl, Sibylle, Linderholm, Barbro, Zoppoli, Gabriele, Davidson, Nancy E., Johannsson, Oskar Th, Bedard, Philippe L., Loi, Sherene, Knox, Susan, Cameron, David A., Harbeck, Nadia, Montoya, Maite Lasa, Brandão, Mariana, Vingiani, Andrea, Caballero, Carmela, Hilbers, Florentine S., Yates, Lucy R., Benelli, Matteo, Venet, David, Piccart, Martine J.
Publicado 2021